Physician Assistant in Wpafb, OH Accepting Medicare

9 Physician Assistant nurses found. Showing 1 - 9

Sandra Swigert, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-9268

Stephen Gene Long, P.A. Physician Assistant - Surgical Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Drive, Wpafb Medical Center, Wpafb, OH 45324 Phone: 937-257-3509    Fax: 937-257-3509

Bryan Rafferty, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 88mdg/sggp, 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-713-9011

Jennifer E Eby, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-1274    Fax: 937-656-1235

Ms. Sara Curtis, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-2778

Mr. Richard Adam Waggoner, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-0770

Mr. Martin Inocentes Vicente, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-4023

Eric Joseph Bailey, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-9222

Mr. Millard Storms Jr., Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6663

News Archive

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Antares Pharma, Inc. announced today that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA), is expected in the third quarter of this year.

Texas budget cutting causes closure of 50 clinics offering family planning services

Cuts to Texas' budget have caused more than 50 clinics that provide family planning services to close, a new study in the New England Journal of Medicine reports.

Migraine drug has quick onset of action

The drug TEV-48125, shown to be effective for chronic migraine in a phase II trial, appears to work within 3 to 7 days of injection, researchers report.

New series of business intelligence tools from Deloitte Recap

Deloitte Recap LLC (Recap) has launched the first two products in the Recap IQ Series by Deloitte, a new subscription service that provides analytical tools built on rich databases tailored toward business development, corporate strategy, financial, legal, tax and R&D professionals.

Study: 90-minute COVID-19 test has high sensitivity and specificity

A 90-minute COVID-19 test has been shown to have over 94 per cent sensitivity, and 100 per cent specificity in a new study.

Read more Medical News

› Verified 5 days ago